{"rows":[{"id":4878,"title":"Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data","authors":"Peter Hess","journal":"The Transmitter","publication_date":"2023-01-01","publication_year":2023,"doi":"10.53053/etcr6498","pubmed_id":null,"openalex_id":"https://openalex.org/W4367666053","source_url":"http://dx.doi.org/10.53053/etcr6498","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology,Clinical Trial","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.53053/etcr6498","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://dx.doi.org/10.53053/etcr6498","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.53053/etcr6498","source_url":"http://dx.doi.org/10.53053/etcr6498","doi":"10.53053/etcr6498","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4877,"title":"Company on brink takes psilocybin to trial for fragile X syndrome","authors":"Peter Hess","journal":"The Transmitter","publication_date":"2023-01-01","publication_year":2023,"doi":"10.53053/mkkk7368","pubmed_id":null,"openalex_id":"https://openalex.org/W4366958553","source_url":"http://dx.doi.org/10.53053/mkkk7368","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.53053/mkkk7368","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.53053/mkkk7368","source_url":"http://dx.doi.org/10.53053/mkkk7368","doi":"10.53053/mkkk7368","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4875,"title":"Going on Trial: Arbaclofen reboot; cell implants; psilocybin microdoses","authors":"Peter Hess","journal":"The Transmitter","publication_date":"2023-01-01","publication_year":2023,"doi":"10.53053/nbdr8957","pubmed_id":null,"openalex_id":"https://openalex.org/W4317889950","source_url":"http://dx.doi.org/10.53053/nbdr8957","substance_tags":"psilocybin","topic_tags":"Microdosing,Clinical Trial","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.53053/nbdr8957","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://dx.doi.org/10.53053/nbdr8957","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.53053/nbdr8957","source_url":"http://dx.doi.org/10.53053/nbdr8957","doi":"10.53053/nbdr8957","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4491,"title":"Psilocybin rewires specific mouse cortical networks in lasting ways","authors":"Siddhant Pusdekar","journal":"The Transmitter","publication_date":"2025-01-01","publication_year":2025,"doi":"10.53053/pkim3530","pubmed_id":null,"openalex_id":"https://openalex.org/W7110395006","source_url":"https://doi.org/10.53053/pkim3530","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Animal Study,Toxicity","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:41","last_checked":"2026-08-09 08:25:25","bibtex":null,"source_record_id":"DOI:10.53053/pkim3530","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.53053/pkim3530","source_url":"https://doi.org/10.53053/pkim3530","doi":"10.53053/pkim3530","pmid":"","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":4,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"The Transmitter","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}